Pramipexole Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: ER tab: 0.375 mg, 0.75 mg, 1.5 mg, 3 mg, 4.5 mg; IR Tab: 0.125 mg, 0.25 mg, 0.5 mg, 0.75 mg, 1 mg, 1.5 mg
Reference Brands: Mirapex®(US), Sifrol® (EU)
Category:
Antipsychotropic Drugs
Pramipexole, a dopamine agonist for Parkinson’s and RLS, is available as 0.125–4.5 mg tablets. Brands include Mirapex® and Sifrol®. Pharma B2B platforms provide bulk access to GMP-certified Pramipexole with global regulatory compliance and consistent supply for hospitals, neurology practices, and pharmaceutical distributors.
Pramipexole is available in Tablets
and strengths such as ER tab: 0.375 mg, 0.75 mg, 1.5 mg, 3 mg, 4.5 mg; IR Tab: 0.125 mg, 0.25 mg, 0.5 mg, 0.75 mg, 1 mg, 1.5 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Pramipexole is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Pramipexole can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Pramipexole is a dopamine agonist used in the treatment of Parkinson’s disease and restless legs syndrome (RLS). It is available in both immediate- and extended-release oral tablet forms with strengths ranging from 0.125 mg to 4.5 mg. Marketed under brands like Mirapex® in the US and Sifrol® in the EU, Pramipexole helps improve motor function and reduce symptoms in neurological disorders. Pharma B2B suppliers offer bulk procurement of Pramipexole from GMP-certified manufacturers, ensuring quality, regulatory compliance, and efficient global supply. Ideal for pharmacies, distributors, and hospital procurement across neurology and chronic care specialties.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing